Genome editing is the effective and precise modification of DNA in the cell. The technique comprises making cuts at particular DNA sequences having enzymes that are known as engineered nucleases. Genome editing technique is used to remove, add, or modify DNA in the genome, which helps to change the characteristics of an organism or cell.
Genome editing is used in three major applications; for disease treatment, for research, and in biotechnology. In research, the technique is used to understand the biology of cells or organisms. In biotechnology, the said technique performs efficiently in order to improve the crop production. In the treatment of diseases, the targeted technique is used to alter human blood cells for curing AIDS or leukemia. Genome editing is also expected to cure disorders like haemophilia and muscular dystrophy. Genome engineering process comprises synthetic assembling of whole chromosomal DNA, gained from natural sequencing process. Thoroughly, genome engineering is a universal approach for synthetic biology and this differentiates it from genetic circuit engineering.
Major Key Players of the Genome Editing/Genome Engineering Market are:Thermo Fisher Scientific, Lonza, Merck, Horizon Discovery Group, Integrated DNA Technologies, New England Biolabs (US), GenScript (US), Sangamo BioSciences (US), OriGene Technologies (US), Transposagen Biopharmaceuticals (US), Editas Medicine (US), and CRISPR Therapeutics (Switzerland)., among others.
Read More @ https://www.openpr.com/news/2014875/genome-editing-genome-engineering-market-detailed-insights
Genome editing is used in three major applications; for disease treatment, for research, and in biotechnology. In research, the technique is used to understand the biology of cells or organisms. In biotechnology, the said technique performs efficiently in order to improve the crop production. In the treatment of diseases, the targeted technique is used to alter human blood cells for curing AIDS or leukemia. Genome editing is also expected to cure disorders like haemophilia and muscular dystrophy. Genome engineering process comprises synthetic assembling of whole chromosomal DNA, gained from natural sequencing process. Thoroughly, genome engineering is a universal approach for synthetic biology and this differentiates it from genetic circuit engineering.
Major Key Players of the Genome Editing/Genome Engineering Market are:Thermo Fisher Scientific, Lonza, Merck, Horizon Discovery Group, Integrated DNA Technologies, New England Biolabs (US), GenScript (US), Sangamo BioSciences (US), OriGene Technologies (US), Transposagen Biopharmaceuticals (US), Editas Medicine (US), and CRISPR Therapeutics (Switzerland)., among others.
Read More @ https://www.openpr.com/news/2014875/genome-editing-genome-engineering-market-detailed-insights
No comments:
Post a Comment